Funds Holding Albany Molecular Research, Inc.

 
Fund Quotes for Funds Holding Albany Molecular Research, Inc. top ^
  • Holdings: Albany Molecular Research Inc , Lakeland Industries Inc , Hawaiian Holdings Inc , Medical Action Industries Inc , John B Sanfilippo & Son Inc ,
  • Category: Small Value
  • Morningstar Rating: 4 Stars
Sign-up for anccx investment picks

 
Stock Quotes for Albany Molecular Research, Inc. top ^
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Core
  • Stock Type: Speculative Growth
Sign-up for amri investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Core
  • Stock Type: Speculative Growth
Sign-up for amri investment picks

 
News Articles for Albany Molecular Research, Inc. top ^
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Albany Molecular Research Inc. (“Albany Molecular” or the “Company”) (NASDAQ:AMRI) concerning possible violations of federal securities laws.
Sign-up for INVESTOR ALERT: Investigation of Albany Molecular Research Inc. Announced by Glancy Binkow & Goldberg LLP investment picks
Kirby McInerney LLP announced today that a class action lawsuit is pending in the United States District Court for the Eastern District of New York on behalf of investors who acquired Albany Molecular Research Inc. (“Albany” or the “Company”) (Nasdaq:AMRI) securities during the period from August 5, 2014 to November 5, 2014 (the “class period”). Pursuant to applicable law, investors have until January 12, 2015 to file a motion to be appointed as lead plaintiff in the investor lawsuit.
Sign-up for Class Action Lawsuit on Behalf of Albany Molecular Research Inc. Investors Announced by Kirby McInerney LLP investment picks
SAN DIEGO and ALBANY, N.Y., Nov.
Sign-up for Robbins Arroyo LLP: Albany Molecular Research, Inc. (AMRI) Misled Shareholders According to a Recently Filed Class Action investment picks
Glancy Binkow & Goldberg LLP announces that a class action lawsuit has been filed in the United States District Court for the Eastern District of New York on behalf of a class (the “Class”) comprising all persons or entities who purchased the common stock of Albany Molecular Research Inc. (“Albany Molecular” or the “Company”) (NASDAQ:AMRI) between August 5, 2014 and November 5, 2014, inclusive (the "Class Period"). If you purchased Albany Molecular shares during the Class Period, you have until January 12, 2015, to ask the Court to appoint you as Lead Plaintiff for the Class.
Sign-up for INVESTOR ALERT: Class Action Lawsuit Against Albany Molecular Research Inc. Announced By Glancy Binkow & Goldberg LLP investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G026865-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/19/11G026865/mw18sbc71j11nkikt31oqs1bfcl832-1291963499582.jpg NEW YORK, NY--(Marketwired - November 19, 2014) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Albany Molecular Research, Inc. ("Albany" or the "Company") (NASDAQ: AMRI) of the January 12, 2015 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Albany and certain officers of the Company.
Sign-up for INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Albany Molecular Research, Inc. (AMRI) to Contact the Firm investment picks
Glancy Binkow & Goldberg LLP reminds investors of Albany Molecular Research Inc. (“Albany Molecular” or the “Company”) (NASDAQ:AMRI) that purchasers of Albany Molecular common stock between August 5, 2014 and November 5, 2014, inclusive (the “Class Period”), have until January 12, 2015, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit Albany Molecular is a contract research and manufacturing company that provides integrated drug discovery, development and manufacturing services primarily in the United States, Europe and Asia.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Albany Molecular Research Inc. investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Funds Holding Albany Molecular Research, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Funds Holding Alaska Air Group, Inc.  |  Next: Funds Holding Albemarle Corp